STOCK TITAN

Veraxa Biotech (VRXA) Stock Price, News & Analysis

VRXA NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
76 249 sessions, November 20, 2025 to November 20, 2026
Largest daily move
-55.5% close of June 16, 2026
1-year change
-90.1% closing prices, November 20, 2025 to November 20, 2026
1-month change
+3% closing prices, October 20, 2026 to November 20, 2026

Company Description

Veraxa Biotech (NASDAQ: VRXA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $147.1M.

VRXA has declined 90.1% over the past year. The last closing price was $1.04.

This page collects what Stock Titan holds for VRXA, including price data, latest news, SEC filings, insider trading activity, upcoming events, and short interest trends.

Stock Performance

$1.04
+0.97%
+0.01
Last updated: at
-90.1%
Performance 1 year
$147.1M

Veraxa Biotech (VRXA) closed at $1.04 on November 20, 2026. Over the past 12 months, the price has lost 90.1%.

See what a $1,000 investment in VRXA would be worth today

Average down calculator for VRXA

VRXA Metrics & Rankings

Price returns through November 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Veraxa Biotech has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include partnership, AI. View all VRXA news →

Insider Radar

Net Buyers
90-Day Summary
95,000
Shares Bought
0
Shares Sold
5
Transactions
Most Recent Transaction
Gruninger Marc (Director) bought 9,133 shares @ $1.00 on October 28, 2026

Insider buying activity at Veraxa Biotech over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

We do not hold any annual figures for Veraxa Biotech yet, so there is nothing to show here.

Upcoming Events

YEAR
2028
2028 Regulatory

VXA-102 IND/CTA readiness

Lead BiTAC-TCE VXA-102 to be IND/CTA-ready by early 2028 (2028-01-01 to 2028-04-30); milestone toward IND filing and clinic.
DEC
31
December 31, 2030 Corporate

Capital band expiry

Capital band approved at July 24, 2026 EGM expires 2030-12-31; governs company’s authorized share issuance flexibility.

Veraxa Biotech has 2 upcoming scheduled events. The next event, "VXA-102 IND/CTA readiness", is expected in 2028. Investors can track these dates to stay informed about potential catalysts that may affect the VRXA stock price.

Short Interest History

Last 12 Months

Short interest in Veraxa Biotech (VRXA) currently stands at 91.2 thousand shares, down 15.1% from the previous reporting period, representing 0.2% of the float. Since June 2026, short interest has increased by 796.4%.

Days to Cover History

Last 12 Months

Days to cover for Veraxa Biotech (VRXA) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.6 days.

VRXA Company Profile & Sector Positioning

Veraxa Biotech (VRXA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing VRXA often look at related companies in the same sector, including InflaRx N.V. (IFRX), Palisade Bio, Inc. (PALI), Eledon Pharmaceuticals, Inc. (ELDN), Atrium Therapeutics, Inc. (RNA), and ProQR Therapeutics N.V. (PRQR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VRXA's relative position within its industry.

Frequently Asked Questions

The current stock price of Veraxa Biotech (VRXA) is $1.04 as of November 20, 2026.

The market cap of Veraxa Biotech (VRXA) is approximately $147.1M. Learn more about what market capitalization means .